| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transformation, Neoplastic | 67 | 2023 | 2829 | 5.220 |
Why?
|
| Telomerase | 50 | 2015 | 747 | 3.690 |
Why?
|
| Neoplasms | 91 | 2023 | 22075 | 2.650 |
Why?
|
| Gene Expression Regulation, Neoplastic | 65 | 2023 | 8512 | 2.500 |
Why?
|
| Cell Line, Tumor | 123 | 2024 | 16932 | 2.360 |
Why?
|
| Oncogenes | 24 | 2023 | 1220 | 2.070 |
Why?
|
| Telomere | 30 | 2012 | 934 | 1.960 |
Why?
|
| Adaptor Proteins, Signal Transducing | 17 | 2022 | 2896 | 1.920 |
Why?
|
| Protein Phosphatase 2 | 15 | 2014 | 236 | 1.870 |
Why?
|
| Phosphoprotein Phosphatases | 10 | 2020 | 330 | 1.770 |
Why?
|
| Genomics | 29 | 2023 | 5795 | 1.680 |
Why?
|
| I-kappa B Kinase | 7 | 2014 | 251 | 1.560 |
Why?
|
| beta Catenin | 11 | 2016 | 1043 | 1.560 |
Why?
|
| ras Proteins | 12 | 2022 | 1051 | 1.460 |
Why?
|
| Genome, Human | 18 | 2021 | 4418 | 1.360 |
Why?
|
| Genes, Essential | 9 | 2023 | 184 | 1.340 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2022 | 2873 | 1.340 |
Why?
|
| TNF Receptor-Associated Factor 2 | 4 | 2013 | 57 | 1.330 |
Why?
|
| Ovarian Neoplasms | 18 | 2022 | 4878 | 1.320 |
Why?
|
| Gene Amplification | 13 | 2023 | 1085 | 1.280 |
Why?
|
| Cell Proliferation | 45 | 2024 | 10442 | 1.240 |
Why?
|
| RNA Interference | 31 | 2023 | 2846 | 1.200 |
Why?
|
| Mice, Nude | 30 | 2022 | 3607 | 1.190 |
Why?
|
| Mutation | 60 | 2021 | 29957 | 1.190 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2021 | 4496 | 1.180 |
Why?
|
| Drug Resistance, Neoplasm | 27 | 2021 | 5251 | 1.180 |
Why?
|
| Signal Transduction | 64 | 2023 | 23374 | 1.180 |
Why?
|
| Receptors, Androgen | 13 | 2022 | 1077 | 1.060 |
Why?
|
| MAP Kinase Signaling System | 11 | 2022 | 1483 | 1.020 |
Why?
|
| Tumor Suppressor Protein p53 | 19 | 2023 | 2924 | 0.980 |
Why?
|
| Antigens, Polyomavirus Transforming | 10 | 2014 | 257 | 0.980 |
Why?
|
| Antineoplastic Agents | 31 | 2021 | 13627 | 0.960 |
Why?
|
| Pancreatic Neoplasms | 12 | 2023 | 5349 | 0.940 |
Why?
|
| DNA-Binding Proteins | 38 | 2023 | 9591 | 0.940 |
Why?
|
| Animals | 167 | 2024 | 167960 | 0.930 |
Why?
|
| Cell Survival | 24 | 2022 | 5797 | 0.910 |
Why?
|
| RNA, Small Interfering | 32 | 2018 | 3442 | 0.890 |
Why?
|
| Neoplasm Proteins | 13 | 2021 | 3612 | 0.890 |
Why?
|
| Gene Dosage | 10 | 2017 | 1218 | 0.880 |
Why?
|
| Protein Kinase Inhibitors | 19 | 2021 | 5640 | 0.870 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 12 | 2022 | 1728 | 0.860 |
Why?
|
| Transcription Factors | 25 | 2022 | 12102 | 0.830 |
Why?
|
| Mice | 120 | 2024 | 81209 | 0.820 |
Why?
|
| Vaccinia | 1 | 2022 | 71 | 0.810 |
Why?
|
| Carcinoma, Medullary | 2 | 2021 | 115 | 0.810 |
Why?
|
| Humans | 345 | 2024 | 760613 | 0.810 |
Why?
|
| RNA-Binding Proteins | 8 | 2022 | 1894 | 0.810 |
Why?
|
| Alleles | 16 | 2021 | 6900 | 0.800 |
Why?
|
| Phosphoproteins | 8 | 2022 | 2440 | 0.790 |
Why?
|
| Peptide Library | 1 | 2022 | 347 | 0.770 |
Why?
|
| Smad4 Protein | 1 | 2021 | 191 | 0.710 |
Why?
|
| Carcinoma, Pancreatic Ductal | 9 | 2023 | 1722 | 0.700 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.690 |
Why?
|
| Fibroblasts | 17 | 2014 | 4089 | 0.690 |
Why?
|
| Androgen Receptor Antagonists | 3 | 2019 | 123 | 0.680 |
Why?
|
| Neuroblastoma | 4 | 2022 | 1252 | 0.670 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2021 | 730 | 0.670 |
Why?
|
| Adenocarcinoma | 15 | 2021 | 6316 | 0.660 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 33 | 0.660 |
Why?
|
| Simian virus 40 | 7 | 2014 | 291 | 0.650 |
Why?
|
| Neoplasms, Experimental | 8 | 2018 | 1229 | 0.640 |
Why?
|
| Gene Silencing | 8 | 2019 | 1512 | 0.640 |
Why?
|
| Ubiquitination | 5 | 2023 | 1008 | 0.640 |
Why?
|
| Prostatic Neoplasms | 26 | 2024 | 11345 | 0.630 |
Why?
|
| Breast Neoplasms | 23 | 2018 | 21029 | 0.630 |
Why?
|
| Genes, ras | 11 | 2017 | 654 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 586 | 0.630 |
Why?
|
| Gene Knockout Techniques | 4 | 2021 | 802 | 0.620 |
Why?
|
| Gene Expression Profiling | 36 | 2023 | 9406 | 0.620 |
Why?
|
| Cyclin-Dependent Kinase 8 | 4 | 2013 | 48 | 0.620 |
Why?
|
| Enzyme Inhibitors | 6 | 2017 | 3725 | 0.620 |
Why?
|
| DNA Damage | 10 | 2020 | 2442 | 0.600 |
Why?
|
| Phosphatidylinositol 3-Kinases | 14 | 2022 | 2864 | 0.590 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2017 | 21 | 0.580 |
Why?
|
| Apoptosis | 23 | 2024 | 9497 | 0.580 |
Why?
|
| Urothelium | 2 | 2019 | 277 | 0.570 |
Why?
|
| Nuclear Proteins | 14 | 2018 | 5795 | 0.570 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 8 | 1993 | 899 | 0.560 |
Why?
|
| Neoplasm Transplantation | 12 | 2019 | 2014 | 0.560 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2019 | 1246 | 0.550 |
Why?
|
| NF-kappa B | 10 | 2014 | 2486 | 0.540 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 126 | 0.540 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2019 | 1313 | 0.540 |
Why?
|
| Proto-Oncogene Proteins B-raf | 15 | 2017 | 2053 | 0.530 |
Why?
|
| Cell Line | 32 | 2023 | 15620 | 0.530 |
Why?
|
| Colonic Neoplasms | 5 | 2022 | 2526 | 0.520 |
Why?
|
| Disease Models, Animal | 18 | 2022 | 18137 | 0.520 |
Why?
|
| Open Reading Frames | 8 | 2019 | 814 | 0.510 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2022 | 895 | 0.510 |
Why?
|
| Oncogene Protein p21(ras) | 3 | 2014 | 68 | 0.510 |
Why?
|
| Genomic Instability | 3 | 2012 | 704 | 0.510 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2013 | 197 | 0.500 |
Why?
|
| Antigens, Viral, Tumor | 4 | 2007 | 153 | 0.500 |
Why?
|
| T-Box Domain Proteins | 2 | 2019 | 468 | 0.480 |
Why?
|
| Cell Division | 22 | 2006 | 4463 | 0.480 |
Why?
|
| Xenograft Model Antitumor Assays | 18 | 2022 | 3583 | 0.480 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 316 | 0.480 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 12 | 0.480 |
Why?
|
| Wnt Proteins | 3 | 2013 | 719 | 0.470 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2012 | 1055 | 0.470 |
Why?
|
| Mutagenesis | 1 | 2018 | 1234 | 0.470 |
Why?
|
| Alternative Splicing | 2 | 2018 | 1091 | 0.470 |
Why?
|
| Drug Synergism | 3 | 2017 | 1752 | 0.470 |
Why?
|
| Cells | 2 | 2021 | 164 | 0.460 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2019 | 2275 | 0.460 |
Why?
|
| p21-Activated Kinases | 2 | 2011 | 128 | 0.450 |
Why?
|
| Gene Targeting | 3 | 2016 | 839 | 0.440 |
Why?
|
| Carcinoma | 2 | 2023 | 2331 | 0.440 |
Why?
|
| Epithelial Cells | 12 | 2012 | 3663 | 0.440 |
Why?
|
| Rhabdoid Tumor | 3 | 2020 | 210 | 0.430 |
Why?
|
| Phosphorylation | 22 | 2022 | 8311 | 0.430 |
Why?
|
| Gene Deletion | 7 | 2018 | 2668 | 0.430 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1455 | 0.430 |
Why?
|
| Receptors, Immunologic | 8 | 1993 | 1414 | 0.420 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2021 | 1596 | 0.420 |
Why?
|
| HEK293 Cells | 13 | 2020 | 4263 | 0.420 |
Why?
|
| raf Kinases | 4 | 2022 | 118 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2013 | 2448 | 0.420 |
Why?
|
| Mammary Glands, Human | 4 | 2019 | 203 | 0.420 |
Why?
|
| Oncogene Proteins | 7 | 2021 | 719 | 0.410 |
Why?
|
| Lung Neoplasms | 15 | 2022 | 13262 | 0.410 |
Why?
|
| Genome | 10 | 2023 | 1739 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2013 | 315 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-myc | 10 | 2019 | 995 | 0.400 |
Why?
|
| Repressor Proteins | 4 | 2022 | 2982 | 0.400 |
Why?
|
| Drug Delivery Systems | 3 | 2021 | 2221 | 0.400 |
Why?
|
| Immunoblotting | 10 | 2016 | 1649 | 0.400 |
Why?
|
| Cell Cycle Proteins | 13 | 2024 | 3448 | 0.390 |
Why?
|
| Telomere-Binding Proteins | 2 | 2011 | 119 | 0.390 |
Why?
|
| Proteins | 6 | 2021 | 6029 | 0.390 |
Why?
|
| Receptor, erbB-2 | 5 | 2017 | 2554 | 0.390 |
Why?
|
| Protein Kinases | 4 | 2017 | 1612 | 0.380 |
Why?
|
| Glioma | 4 | 2022 | 3420 | 0.380 |
Why?
|
| Brain Neoplasms | 9 | 2017 | 8985 | 0.380 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2018 | 3617 | 0.380 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2023 | 2536 | 0.380 |
Why?
|
| Quinazolines | 4 | 2014 | 1363 | 0.380 |
Why?
|
| Retinoblastoma Protein | 7 | 2017 | 670 | 0.370 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2014 | 487 | 0.370 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2007 | 9 | 0.370 |
Why?
|
| Cell Line, Transformed | 6 | 2011 | 869 | 0.370 |
Why?
|
| RNA, Untranslated | 2 | 2011 | 459 | 0.360 |
Why?
|
| DNA Mutational Analysis | 14 | 2021 | 4108 | 0.360 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 8 | 2016 | 698 | 0.350 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 479 | 0.350 |
Why?
|
| DNA Copy Number Variations | 5 | 2017 | 2013 | 0.350 |
Why?
|
| HCT116 Cells | 5 | 2019 | 402 | 0.350 |
Why?
|
| Gene Library | 6 | 2021 | 1060 | 0.340 |
Why?
|
| Epigenesis, Genetic | 7 | 2017 | 3759 | 0.340 |
Why?
|
| Models, Biological | 11 | 2018 | 9468 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2021 | 17790 | 0.340 |
Why?
|
| Cell Lineage | 7 | 2019 | 2532 | 0.340 |
Why?
|
| Thiazoles | 1 | 2017 | 1511 | 0.340 |
Why?
|
| Gene Expression | 12 | 2022 | 7587 | 0.330 |
Why?
|
| Genetic Vectors | 9 | 2011 | 3380 | 0.330 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2014 | 341 | 0.330 |
Why?
|
| Kidney Neoplasms | 3 | 2024 | 4312 | 0.330 |
Why?
|
| Glioblastoma | 7 | 2014 | 3482 | 0.330 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1888 | 0.330 |
Why?
|
| Molecular Targeted Therapy | 8 | 2021 | 2803 | 0.330 |
Why?
|
| Triazoles | 5 | 2024 | 904 | 0.330 |
Why?
|
| Colorectal Neoplasms | 9 | 2023 | 6853 | 0.330 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2021 | 209 | 0.320 |
Why?
|
| Genome-Wide Association Study | 9 | 2021 | 12628 | 0.320 |
Why?
|
| Protein Subunits | 7 | 2014 | 943 | 0.320 |
Why?
|
| Proteomics | 6 | 2020 | 3817 | 0.320 |
Why?
|
| Diploidy | 1 | 2008 | 132 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 567 | 0.320 |
Why?
|
| Computational Biology | 8 | 2024 | 3505 | 0.310 |
Why?
|
| bcl-X Protein | 4 | 2020 | 413 | 0.310 |
Why?
|
| Janus Kinase 2 | 4 | 2018 | 542 | 0.310 |
Why?
|
| Neoplasm Invasiveness | 7 | 2013 | 3618 | 0.310 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 3844 | 0.310 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 190 | 0.310 |
Why?
|
| Organoids | 5 | 2022 | 729 | 0.310 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2019 | 656 | 0.310 |
Why?
|
| Protein-Arginine N-Methyltransferases | 3 | 2022 | 131 | 0.310 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2024 | 81 | 0.300 |
Why?
|
| Enzyme Activation | 10 | 2011 | 3602 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2012 | 2802 | 0.300 |
Why?
|
| Karyopherins | 4 | 2024 | 130 | 0.300 |
Why?
|
| Genes | 3 | 2024 | 1845 | 0.300 |
Why?
|
| Chordoma | 2 | 2023 | 346 | 0.300 |
Why?
|
| RNA | 9 | 2023 | 2723 | 0.300 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1634 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2024 | 319 | 0.290 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 1035 | 0.290 |
Why?
|
| Base Sequence | 13 | 2018 | 12444 | 0.290 |
Why?
|
| Transcription, Genetic | 13 | 2018 | 7593 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2018 | 6552 | 0.280 |
Why?
|
| Prostate | 6 | 2022 | 1793 | 0.280 |
Why?
|
| Cell Cycle | 9 | 2019 | 2935 | 0.270 |
Why?
|
| Drug Screening Assays, Antitumor | 5 | 2020 | 717 | 0.270 |
Why?
|
| Ubiquitins | 2 | 2023 | 370 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 368 | 0.260 |
Why?
|
| Benzamides | 5 | 2019 | 1369 | 0.260 |
Why?
|
| Female | 76 | 2022 | 391246 | 0.260 |
Why?
|
| Janus Kinase 1 | 2 | 2018 | 107 | 0.250 |
Why?
|
| Chromosome Mapping | 4 | 2022 | 4626 | 0.250 |
Why?
|
| Astrocytoma | 3 | 2017 | 775 | 0.250 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2015 | 302 | 0.250 |
Why?
|
| Tumor Cells, Cultured | 15 | 2021 | 6130 | 0.250 |
Why?
|
| Transduction, Genetic | 4 | 2014 | 897 | 0.250 |
Why?
|
| Cyclin E | 3 | 2014 | 155 | 0.240 |
Why?
|
| NIH 3T3 Cells | 6 | 2012 | 670 | 0.240 |
Why?
|
| Cells, Cultured | 19 | 2018 | 18955 | 0.240 |
Why?
|
| Cholangiocarcinoma | 2 | 2021 | 548 | 0.240 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 165 | 0.240 |
Why?
|
| Cloning, Molecular | 5 | 2012 | 4169 | 0.240 |
Why?
|
| Databases, Genetic | 6 | 2021 | 1738 | 0.240 |
Why?
|
| Hydrazines | 2 | 2024 | 224 | 0.230 |
Why?
|
| Protein Binding | 16 | 2022 | 9335 | 0.230 |
Why?
|
| Tumor Escape | 2 | 2021 | 370 | 0.230 |
Why?
|
| Transcriptional Activation | 4 | 2022 | 1754 | 0.230 |
Why?
|
| DNA Helicases | 5 | 2023 | 854 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 4 | 5 | 2019 | 556 | 0.230 |
Why?
|
| Bone Neoplasms | 4 | 2023 | 2531 | 0.230 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2017 | 256 | 0.230 |
Why?
|
| Lentivirus | 4 | 2011 | 506 | 0.230 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2011 | 616 | 0.230 |
Why?
|
| DNA | 7 | 2018 | 7233 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2022 | 7850 | 0.220 |
Why?
|
| Pyrimidinones | 2 | 2017 | 384 | 0.220 |
Why?
|
| High-Throughput Screening Assays | 4 | 2017 | 944 | 0.220 |
Why?
|
| Chromatin | 7 | 2018 | 2938 | 0.220 |
Why?
|
| Thrombospondins | 1 | 2004 | 193 | 0.220 |
Why?
|
| Down-Regulation | 8 | 2019 | 2913 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 6 | 4 | 2019 | 346 | 0.220 |
Why?
|
| HeLa Cells | 14 | 2017 | 3105 | 0.220 |
Why?
|
| Retroviridae | 7 | 2012 | 850 | 0.220 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 3709 | 0.220 |
Why?
|
| Mice, SCID | 8 | 2019 | 2627 | 0.220 |
Why?
|
| Ubiquitin | 2 | 2019 | 838 | 0.220 |
Why?
|
| Androgens | 5 | 2010 | 1291 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2021 | 1356 | 0.210 |
Why?
|
| Gene Expression Regulation | 13 | 2020 | 11902 | 0.210 |
Why?
|
| Melanoma | 10 | 2017 | 5697 | 0.210 |
Why?
|
| Cell Differentiation | 12 | 2023 | 11481 | 0.210 |
Why?
|
| Histones | 9 | 2019 | 2582 | 0.210 |
Why?
|
| Amino Acid Sequence | 14 | 2013 | 13451 | 0.210 |
Why?
|
| Pyridones | 3 | 2017 | 792 | 0.210 |
Why?
|
| Cell Transformation, Viral | 4 | 2014 | 526 | 0.210 |
Why?
|
| Protein Biosynthesis | 3 | 2020 | 2104 | 0.210 |
Why?
|
| Genetic Testing | 5 | 2018 | 3531 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 5 | 2020 | 1617 | 0.200 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 800 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2024 | 854 | 0.200 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2019 | 3610 | 0.200 |
Why?
|
| Anoikis | 2 | 2014 | 48 | 0.200 |
Why?
|
| Molecular Biology | 2 | 2004 | 580 | 0.200 |
Why?
|
| Protein Phosphatase 1 | 1 | 2022 | 134 | 0.200 |
Why?
|
| Multiple Myeloma | 5 | 2023 | 5131 | 0.200 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2015 | 332 | 0.200 |
Why?
|
| Homeodomain Proteins | 6 | 2016 | 2414 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 4 | 2012 | 2640 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2015 | 5251 | 0.190 |
Why?
|
| Transplantation, Heterologous | 7 | 2017 | 2379 | 0.190 |
Why?
|
| Molecular Sequence Data | 13 | 2014 | 17624 | 0.190 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 196 | 0.190 |
Why?
|
| Neoplastic Stem Cells | 2 | 2006 | 1347 | 0.190 |
Why?
|
| Wilms Tumor | 1 | 2024 | 375 | 0.190 |
Why?
|
| Urologic Neoplasms | 2 | 2016 | 320 | 0.190 |
Why?
|
| Transfection | 10 | 2010 | 5781 | 0.190 |
Why?
|
| Calmodulin | 1 | 2022 | 217 | 0.190 |
Why?
|
| Phenylthiohydantoin | 2 | 2019 | 204 | 0.190 |
Why?
|
| Antigens, CD | 6 | 1993 | 4000 | 0.180 |
Why?
|
| Vaccinia virus | 1 | 2022 | 331 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 7 | 2018 | 4716 | 0.180 |
Why?
|
| Root Canal Irrigants | 1 | 2000 | 15 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4571 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3774 | 0.180 |
Why?
|
| Lysine | 3 | 2014 | 1001 | 0.180 |
Why?
|
| Sodium Hypochlorite | 1 | 2000 | 31 | 0.180 |
Why?
|
| HT29 Cells | 2 | 2017 | 190 | 0.180 |
Why?
|
| Genes, Lethal | 2 | 2011 | 225 | 0.180 |
Why?
|
| Semantics | 1 | 2024 | 599 | 0.180 |
Why?
|
| Neoplasm Metastasis | 7 | 2021 | 4902 | 0.170 |
Why?
|
| Antigens, Neoplasm | 3 | 2022 | 1998 | 0.170 |
Why?
|
| Multiprotein Complexes | 3 | 2022 | 1120 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 6216 | 0.170 |
Why?
|
| Drug Discovery | 4 | 2011 | 1057 | 0.170 |
Why?
|
| Population Dynamics | 1 | 2021 | 306 | 0.170 |
Why?
|
| Asparagine | 2 | 2019 | 119 | 0.170 |
Why?
|
| Exons | 5 | 2018 | 2389 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2019 | 2505 | 0.170 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 150 | 0.170 |
Why?
|
| Catalysis | 3 | 2017 | 775 | 0.170 |
Why?
|
| Nervous System | 1 | 2022 | 543 | 0.160 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 196 | 0.160 |
Why?
|
| Azepines | 2 | 2019 | 330 | 0.160 |
Why?
|
| Models, Genetic | 5 | 2018 | 3442 | 0.160 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 307 | 0.160 |
Why?
|
| Phenotype | 16 | 2023 | 16548 | 0.160 |
Why?
|
| Male | 56 | 2024 | 359718 | 0.160 |
Why?
|
| False Positive Reactions | 3 | 2017 | 956 | 0.160 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20080 | 0.160 |
Why?
|
| Fetal Proteins | 1 | 2019 | 97 | 0.160 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2020 | 232 | 0.160 |
Why?
|
| Protease Inhibitors | 2 | 2020 | 755 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2018 | 635 | 0.160 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 642 | 0.150 |
Why?
|
| Bronchi | 1 | 2002 | 848 | 0.150 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2018 | 49 | 0.150 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 144 | 0.150 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 45 | 0.150 |
Why?
|
| Germ-Line Mutation | 3 | 2021 | 1842 | 0.150 |
Why?
|
| Fusobacterium | 1 | 2017 | 54 | 0.150 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2014 | 412 | 0.150 |
Why?
|
| Translocation, Genetic | 2 | 2017 | 1388 | 0.150 |
Why?
|
| Indoles | 5 | 2015 | 1829 | 0.150 |
Why?
|
| T-Lymphocytes | 7 | 1995 | 10181 | 0.150 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2018 | 633 | 0.150 |
Why?
|
| Protein Isoforms | 3 | 2018 | 1697 | 0.150 |
Why?
|
| Nitriles | 2 | 2019 | 956 | 0.150 |
Why?
|
| Mass Spectrometry | 3 | 2011 | 2192 | 0.150 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1997 | 58 | 0.140 |
Why?
|
| Microsatellite Instability | 2 | 2019 | 715 | 0.140 |
Why?
|
| DNA Methylation | 8 | 2019 | 4372 | 0.140 |
Why?
|
| 14-3-3 Proteins | 2 | 2010 | 221 | 0.140 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2014 | 938 | 0.140 |
Why?
|
| Genetic Fitness | 1 | 2018 | 116 | 0.140 |
Why?
|
| Chemokine CCL5 | 2 | 2014 | 215 | 0.140 |
Why?
|
| Disease Progression | 7 | 2024 | 13505 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2017 | 279 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2013 | 4024 | 0.140 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
| Adenosine Deaminase | 1 | 2018 | 251 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2021 | 67 | 0.140 |
Why?
|
| Mouth Neoplasms | 4 | 2005 | 593 | 0.140 |
Why?
|
| Lipid Peroxidation | 1 | 2017 | 271 | 0.130 |
Why?
|
| RNA, Messenger | 8 | 2018 | 12762 | 0.130 |
Why?
|
| Genotype | 8 | 2021 | 12957 | 0.130 |
Why?
|
| Models, Immunological | 1 | 2018 | 513 | 0.130 |
Why?
|
| Cell Death | 4 | 2017 | 1671 | 0.130 |
Why?
|
| Glutathione | 1 | 2019 | 582 | 0.130 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 198 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 2005 | 0.130 |
Why?
|
| Metronidazole | 1 | 2017 | 231 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1613 | 0.130 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2016 | 28 | 0.130 |
Why?
|
| Glutathione Peroxidase | 1 | 2017 | 256 | 0.130 |
Why?
|
| DNA Cleavage | 1 | 2016 | 57 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2012 | 358 | 0.130 |
Why?
|
| Up-Regulation | 6 | 2017 | 4122 | 0.130 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 230 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2017 | 241 | 0.130 |
Why?
|
| Catalytic Domain | 5 | 2019 | 706 | 0.130 |
Why?
|
| Cyclin D1 | 3 | 2009 | 451 | 0.130 |
Why?
|
| Sirtuin 1 | 2 | 2015 | 247 | 0.130 |
Why?
|
| Cell Adhesion | 10 | 2016 | 3094 | 0.130 |
Why?
|
| Mutation, Missense | 3 | 2022 | 2567 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2018 | 305 | 0.130 |
Why?
|
| Autocrine Communication | 2 | 2014 | 169 | 0.130 |
Why?
|
| Receptor, trkB | 1 | 2016 | 125 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2012 | 92 | 0.130 |
Why?
|
| Bile Duct Neoplasms | 1 | 2021 | 601 | 0.130 |
Why?
|
| Genes, myc | 4 | 2009 | 395 | 0.130 |
Why?
|
| Goals | 1 | 2021 | 708 | 0.130 |
Why?
|
| Natural Language Processing | 1 | 2024 | 1135 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2017 | 345 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 428 | 0.120 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 2716 | 0.120 |
Why?
|
| Serine Endopeptidases | 2 | 2018 | 1021 | 0.120 |
Why?
|
| Gene Regulatory Networks | 4 | 2018 | 1741 | 0.120 |
Why?
|
| Plasmids | 5 | 2011 | 2275 | 0.120 |
Why?
|
| Haplotypes | 1 | 2021 | 2764 | 0.120 |
Why?
|
| Blotting, Southern | 3 | 2011 | 777 | 0.120 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2014 | 111 | 0.120 |
Why?
|
| G1 Phase | 2 | 2014 | 403 | 0.120 |
Why?
|
| Sarcoma | 2 | 2016 | 1786 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2019 | 870 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 410 | 0.120 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 503 | 0.120 |
Why?
|
| Binding Sites | 7 | 2022 | 6048 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Antibodies | 1 | 2022 | 2421 | 0.120 |
Why?
|
| Interferons | 3 | 2018 | 705 | 0.120 |
Why?
|
| Keratinocytes | 4 | 2005 | 792 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 650 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2017 | 983 | 0.120 |
Why?
|
| Pyrimidines | 6 | 2019 | 3016 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 617 | 0.120 |
Why?
|
| Endonucleases | 1 | 2017 | 370 | 0.120 |
Why?
|
| HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
| DNA, Complementary | 4 | 2010 | 1991 | 0.120 |
Why?
|
| International Cooperation | 1 | 2021 | 1433 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 586 | 0.120 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 102 | 0.120 |
Why?
|
| G-Quadruplexes | 1 | 2017 | 190 | 0.120 |
Why?
|
| DNA Repair | 6 | 2020 | 2038 | 0.110 |
Why?
|
| G2 Phase | 1 | 2014 | 133 | 0.110 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2698 | 0.110 |
Why?
|
| Nanoparticles | 2 | 2018 | 1943 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5782 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2014 | 106 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2019 | 678 | 0.110 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 51 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2015 | 645 | 0.110 |
Why?
|
| Libraries | 2 | 2010 | 21 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1745 | 0.110 |
Why?
|
| S Phase | 2 | 2019 | 422 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2014 | 1693 | 0.110 |
Why?
|
| Cathepsins | 1 | 2014 | 242 | 0.110 |
Why?
|
| MicroRNAs | 4 | 2019 | 3787 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2013 | 1173 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2012 | 14 | 0.110 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 114 | 0.110 |
Why?
|
| Software | 3 | 2018 | 4419 | 0.110 |
Why?
|
| Immunohistochemistry | 6 | 2018 | 11070 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2015 | 728 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 55 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2014 | 430 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2013 | 183 | 0.110 |
Why?
|
| Polyploidy | 1 | 2013 | 119 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 508 | 0.110 |
Why?
|
| Leukemia | 2 | 2015 | 1523 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2014 | 267 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2014 | 314 | 0.110 |
Why?
|
| Glycolysis | 1 | 2017 | 828 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.110 |
Why?
|
| Mediator Complex | 1 | 2013 | 106 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2018 | 1187 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 1993 | 0.100 |
Why?
|
| DNA Primers | 3 | 2012 | 2818 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2010 | 2418 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2019 | 855 | 0.100 |
Why?
|
| Acetylation | 4 | 2018 | 1062 | 0.100 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2012 | 58 | 0.100 |
Why?
|
| Boronic Acids | 2 | 2013 | 914 | 0.100 |
Why?
|
| Adenoma | 1 | 2023 | 2148 | 0.100 |
Why?
|
| Hybridomas | 5 | 1993 | 442 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 410 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2012 | 112 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2010 | 52 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2015 | 374 | 0.100 |
Why?
|
| src-Family Kinases | 2 | 2012 | 535 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 2014 | 188 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2012 | 102 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 8055 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 3 | 2011 | 877 | 0.100 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2014 | 194 | 0.100 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 724 | 0.100 |
Why?
|
| Pyridines | 5 | 2016 | 2879 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
| Pyrophosphatases | 1 | 2012 | 139 | 0.100 |
Why?
|
| SOS1 Protein | 1 | 2011 | 40 | 0.100 |
Why?
|
| Forecasting | 1 | 2021 | 2931 | 0.100 |
Why?
|
| Cyclic AMP | 3 | 1995 | 1456 | 0.100 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2012 | 158 | 0.100 |
Why?
|
| Antibody Affinity | 1 | 1992 | 245 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 15790 | 0.100 |
Why?
|
| Serine | 3 | 2010 | 831 | 0.100 |
Why?
|
| Osteosarcoma | 1 | 2017 | 897 | 0.100 |
Why?
|
| Genomic Library | 1 | 2011 | 189 | 0.090 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1357 | 0.090 |
Why?
|
| Arthritis, Experimental | 2 | 2003 | 291 | 0.090 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 877 | 0.090 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Quinolines | 2 | 2014 | 759 | 0.090 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 277 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 788 | 0.090 |
Why?
|
| Antioxidants | 1 | 2019 | 1667 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 260 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 1245 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 619 | 0.090 |
Why?
|
| Herbal Medicine | 1 | 2010 | 36 | 0.090 |
Why?
|
| Mice, Inbred NOD | 5 | 2014 | 1837 | 0.090 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 657 | 0.090 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 169 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 207 | 0.090 |
Why?
|
| Pyrazines | 2 | 2013 | 1199 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 679 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 346 | 0.090 |
Why?
|
| Phloroglucinol | 1 | 2010 | 6 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 61 | 0.090 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2010 | 73 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 611 | 0.090 |
Why?
|
| Astrocytes | 2 | 2016 | 1337 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 10826 | 0.090 |
Why?
|
| Models, Molecular | 4 | 2011 | 5434 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 383 | 0.090 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 192 | 0.090 |
Why?
|
| Plants, Medicinal | 1 | 2010 | 166 | 0.090 |
Why?
|
| Neurofibromin 1 | 1 | 2011 | 190 | 0.090 |
Why?
|
| Nervous System Neoplasms | 1 | 2010 | 91 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 276 | 0.090 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 435 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2012 | 548 | 0.090 |
Why?
|
| WT1 Proteins | 1 | 2010 | 184 | 0.090 |
Why?
|
| Blotting, Northern | 1 | 2011 | 1543 | 0.090 |
Why?
|
| Methylation | 4 | 2015 | 1081 | 0.090 |
Why?
|
| Peptides | 4 | 2018 | 4354 | 0.090 |
Why?
|
| Melanocytes | 3 | 2014 | 512 | 0.090 |
Why?
|
| Interleukin-6 | 3 | 2014 | 3215 | 0.090 |
Why?
|
| Radiation, Ionizing | 2 | 2013 | 251 | 0.080 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2009 | 81 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2001 | 1765 | 0.080 |
Why?
|
| Lymphocyte Activation | 6 | 2001 | 5496 | 0.080 |
Why?
|
| Azacitidine | 1 | 2011 | 334 | 0.080 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2010 | 93 | 0.080 |
Why?
|
| Small Molecule Libraries | 3 | 2019 | 734 | 0.080 |
Why?
|
| Autoantigens | 1 | 2014 | 877 | 0.080 |
Why?
|
| Cell Nucleus | 5 | 2018 | 2907 | 0.080 |
Why?
|
| Uveal Neoplasms | 1 | 2012 | 341 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 620 | 0.080 |
Why?
|
| Neuregulin-1 | 1 | 2010 | 135 | 0.080 |
Why?
|
| Time Factors | 11 | 2015 | 40139 | 0.080 |
Why?
|
| Blotting, Western | 6 | 2012 | 5039 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 2010 | 292 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2013 | 699 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4408 | 0.080 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 929 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 537 | 0.080 |
Why?
|
| Receptor, erbB-3 | 1 | 2010 | 143 | 0.080 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 151 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2009 | 99 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2009 | 112 | 0.080 |
Why?
|
| Breast | 2 | 2012 | 1963 | 0.080 |
Why?
|
| Mitosis | 3 | 2014 | 1191 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2010 | 295 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2003 | 1526 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 748 | 0.080 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.080 |
Why?
|
| Heterochromatin | 1 | 2011 | 293 | 0.080 |
Why?
|
| Kidney | 3 | 2019 | 7064 | 0.080 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2008 | 58 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2009 | 675 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2014 | 709 | 0.080 |
Why?
|
| Disease-Free Survival | 5 | 2018 | 6831 | 0.080 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2005 | 84 | 0.080 |
Why?
|
| Stomach Neoplasms | 2 | 2019 | 1424 | 0.080 |
Why?
|
| Cell Movement | 6 | 2020 | 5206 | 0.080 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 286 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 2003 | 315 | 0.070 |
Why?
|
| Stem Cells | 2 | 2011 | 3524 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2009 | 229 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1387 | 0.070 |
Why?
|
| Blast Crisis | 1 | 2008 | 101 | 0.070 |
Why?
|
| Sulfonamides | 3 | 2014 | 1977 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 640 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1613 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2015 | 1999 | 0.070 |
Why?
|
| Esophageal Neoplasms | 2 | 2009 | 1648 | 0.070 |
Why?
|
| Colon | 2 | 2012 | 1788 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3800 | 0.070 |
Why?
|
| Algorithms | 7 | 2021 | 13982 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2018 | 607 | 0.070 |
Why?
|
| Genes, p53 | 4 | 2003 | 713 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 206 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 277 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 999 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 1991 | 1608 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2013 | 1147 | 0.070 |
Why?
|
| Imidazoles | 1 | 2013 | 1180 | 0.070 |
Why?
|
| cdc25 Phosphatases | 1 | 2006 | 60 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 951 | 0.070 |
Why?
|
| Multigene Family | 2 | 2013 | 1077 | 0.070 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 329 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 4 | 2010 | 465 | 0.070 |
Why?
|
| Ribonucleoproteins | 1 | 2009 | 372 | 0.070 |
Why?
|
| Mice, Transgenic | 7 | 2018 | 9530 | 0.070 |
Why?
|
| Aminopyridines | 3 | 2019 | 565 | 0.070 |
Why?
|
| Genetic Engineering | 3 | 2010 | 933 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 22020 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2009 | 542 | 0.070 |
Why?
|
| Solubility | 2 | 2005 | 1088 | 0.070 |
Why?
|
| Zebrafish | 2 | 2020 | 2997 | 0.070 |
Why?
|
| Feline panleukopenia virus | 1 | 1985 | 1 | 0.070 |
Why?
|
| Parvoviridae | 1 | 1985 | 7 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2013 | 2860 | 0.060 |
Why?
|
| Karyotyping | 3 | 2002 | 1172 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7408 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 476 | 0.060 |
Why?
|
| Haploidy | 1 | 2005 | 133 | 0.060 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14374 | 0.060 |
Why?
|
| Research Design | 2 | 2011 | 6180 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 642 | 0.060 |
Why?
|
| Prognosis | 5 | 2023 | 29661 | 0.060 |
Why?
|
| Arteries | 1 | 2010 | 1126 | 0.060 |
Why?
|
| Sirtuins | 1 | 2008 | 320 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 1313 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3426 | 0.060 |
Why?
|
| Precancerous Conditions | 2 | 2010 | 977 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 5 | 2015 | 6065 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 5799 | 0.060 |
Why?
|
| CDC2 Protein Kinase | 1 | 2005 | 213 | 0.060 |
Why?
|
| Xenopus | 1 | 2006 | 717 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2012 | 2471 | 0.060 |
Why?
|
| DNA Replication | 3 | 2011 | 1412 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 9278 | 0.060 |
Why?
|
| Mitogens | 1 | 2004 | 230 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3085 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2024 | 2208 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3486 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8950 | 0.060 |
Why?
|
| Kinetics | 4 | 2003 | 6377 | 0.060 |
Why?
|
| Meningioma | 1 | 2013 | 1221 | 0.060 |
Why?
|
| RNA Splicing | 2 | 2019 | 915 | 0.060 |
Why?
|
| Cell Growth Processes | 3 | 2010 | 384 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 435 | 0.060 |
Why?
|
| Genetic Techniques | 2 | 2023 | 428 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 423 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2015 | 2313 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2004 | 177 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2011 | 3970 | 0.060 |
Why?
|
| Agar | 1 | 2003 | 55 | 0.060 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 2 | 1993 | 67 | 0.050 |
Why?
|
| Child | 7 | 2022 | 79799 | 0.050 |
Why?
|
| Interleukins | 1 | 2008 | 786 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 3734 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 6544 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 2203 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2003 | 311 | 0.050 |
Why?
|
| Cell Culture Techniques | 3 | 2009 | 1664 | 0.050 |
Why?
|
| Adult | 18 | 2021 | 220007 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2013 | 2003 | 0.050 |
Why?
|
| Protein Array Analysis | 2 | 2019 | 401 | 0.050 |
Why?
|
| Piperazines | 3 | 2016 | 2525 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2024 | 435 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2003 | 283 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 1928 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 814 | 0.050 |
Why?
|
| Middle Aged | 16 | 2021 | 220359 | 0.050 |
Why?
|
| Sirolimus | 1 | 2009 | 1547 | 0.050 |
Why?
|
| Claudins | 1 | 2023 | 115 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2014 | 1085 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2014 | 4742 | 0.050 |
Why?
|
| HLA-A3 Antigen | 1 | 2001 | 34 | 0.050 |
Why?
|
| Genes, Neoplasm | 2 | 2016 | 370 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 255 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2003 | 242 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2018 | 1342 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 916 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 316 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 818 | 0.050 |
Why?
|
| Aged | 14 | 2021 | 169143 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11713 | 0.050 |
Why?
|
| DNA Breaks | 1 | 2021 | 47 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2013 | 473 | 0.050 |
Why?
|
| Ischemia | 1 | 2010 | 1893 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4356 | 0.050 |
Why?
|
| Genes, Immediate-Early | 1 | 2001 | 101 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2013 | 3905 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2651 | 0.050 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2002 | 117 | 0.050 |
Why?
|
| Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2003 | 480 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2001 | 67 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2618 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 215 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2176 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 585 | 0.050 |
Why?
|
| Chile | 1 | 2021 | 255 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 593 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4542 | 0.050 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2008 | 936 | 0.050 |
Why?
|
| Homeostasis | 3 | 2011 | 3306 | 0.050 |
Why?
|
| Oral Hemorrhage | 1 | 2000 | 24 | 0.050 |
Why?
|
| Subcutaneous Emphysema | 1 | 2000 | 15 | 0.050 |
Why?
|
| U937 Cells | 2 | 2012 | 262 | 0.050 |
Why?
|
| Protein Stability | 1 | 2022 | 566 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3142 | 0.040 |
Why?
|
| Integrins | 2 | 2021 | 839 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 256 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2019 | 1895 | 0.040 |
Why?
|
| HL-60 Cells | 2 | 2012 | 363 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 1132 | 0.040 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2014 | 259 | 0.040 |
Why?
|
| Mice, Hairless | 1 | 2019 | 39 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2004 | 1084 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 454 | 0.040 |
Why?
|
| Eye Burns | 1 | 2000 | 65 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2022 | 929 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2000 | 101 | 0.040 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2019 | 11 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 2019 | 17 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 23 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2020 | 1895 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1408 | 0.040 |
Why?
|
| Ovary | 1 | 2004 | 958 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1019 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
| Ubiquitinated Proteins | 1 | 2019 | 32 | 0.040 |
Why?
|
| Burns, Chemical | 1 | 2000 | 122 | 0.040 |
Why?
|
| Thiocyanates | 1 | 2019 | 70 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4550 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 2 | 2014 | 833 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2012 | 380 | 0.040 |
Why?
|
| Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 2057 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2014 | 431 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2018 | 73 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 139 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2022 | 639 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 869 | 0.040 |
Why?
|
| DNA, Viral | 1 | 1985 | 2194 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2022 | 362 | 0.040 |
Why?
|
| Genetic Complementation Test | 2 | 2014 | 555 | 0.040 |
Why?
|
| Phosphates | 1 | 2022 | 772 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3047 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1898 | 0.040 |
Why?
|
| Morpholines | 2 | 2013 | 583 | 0.040 |
Why?
|
| Gene Rearrangement | 2 | 2015 | 1122 | 0.040 |
Why?
|
| Viral Proteins | 1 | 1985 | 1802 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 4938 | 0.040 |
Why?
|
| Rats | 5 | 2020 | 23709 | 0.040 |
Why?
|
| Cell Nucleolus | 2 | 2011 | 156 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 630 | 0.040 |
Why?
|
| Prevotella | 1 | 2017 | 80 | 0.040 |
Why?
|
| Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 640 | 0.040 |
Why?
|
| Virus Replication | 1 | 2005 | 2432 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
| Gingival Hyperplasia | 1 | 1997 | 19 | 0.040 |
Why?
|
| Asparaginase | 1 | 2019 | 240 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2017 | 74 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2017 | 66 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 747 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 311 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 271 | 0.040 |
Why?
|
| Bacteroides | 1 | 2017 | 165 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 2 | 1995 | 1602 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2013 | 41337 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1398 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2018 | 231 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2012 | 1792 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2019 | 863 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 732 | 0.030 |
Why?
|
| Thionucleosides | 1 | 2016 | 13 | 0.030 |
Why?
|
| Deoxyadenosines | 1 | 2016 | 27 | 0.030 |
Why?
|
| Pharmacogenetics | 2 | 2012 | 680 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 185 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1999 | 618 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 1046 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2117 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 877 | 0.030 |
Why?
|
| Microscopy | 1 | 2021 | 885 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2013 | 1982 | 0.030 |
Why?
|
| Albumins | 1 | 2018 | 577 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2018 | 865 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10185 | 0.030 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2015 | 24 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 936 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 1992 | 1889 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2014 | 5869 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
| Cystatins | 1 | 2014 | 55 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2012 | 1189 | 0.030 |
Why?
|
| Oxidative Stress | 3 | 2019 | 3106 | 0.030 |
Why?
|
| Benzocycloheptenes | 1 | 2014 | 9 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 516 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 1705 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 353 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2262 | 0.030 |
Why?
|
| Drug Design | 1 | 1999 | 1061 | 0.030 |
Why?
|
| United States | 4 | 2021 | 72448 | 0.030 |
Why?
|
| Mesoderm | 1 | 2017 | 672 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
| Chromosomes | 1 | 2017 | 575 | 0.030 |
Why?
|
| Cell Communication | 2 | 2008 | 1653 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 872 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1907 | 0.030 |
Why?
|
| Spleen Focus-Forming Viruses | 1 | 1993 | 16 | 0.030 |
Why?
|
| Adolescent | 6 | 2022 | 87809 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2014 | 228 | 0.030 |
Why?
|
| Friend murine leukemia virus | 1 | 1993 | 37 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64981 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58980 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2014 | 250 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1993 | 152 | 0.030 |
Why?
|
| Bucladesine | 1 | 1993 | 118 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 42 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 418 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2018 | 810 | 0.030 |
Why?
|
| Young Adult | 5 | 2021 | 58748 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 212 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 116 | 0.030 |
Why?
|
| GATA4 Transcription Factor | 1 | 2013 | 124 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2008 | 1553 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1137 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2825 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 1442 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1347 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 265 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 858 | 0.030 |
Why?
|
| Genes, erbB-1 | 1 | 2013 | 160 | 0.030 |
Why?
|
| Serpins | 1 | 2014 | 247 | 0.030 |
Why?
|
| Neurons | 2 | 2017 | 9424 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 852 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 898 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2012 | 63 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 1189 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14661 | 0.030 |
Why?
|
| Mammals | 1 | 2018 | 1131 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2018 | 1521 | 0.030 |
Why?
|
| TYK2 Kinase | 1 | 2012 | 37 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4319 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 2003 | 622 | 0.030 |
Why?
|
| HLA-A2 Antigen | 2 | 2004 | 211 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2009 | 1529 | 0.030 |
Why?
|
| Remission Induction | 1 | 2018 | 2392 | 0.030 |
Why?
|
| Gentamicins | 1 | 1993 | 252 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1131 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 786 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2012 | 77 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 982 | 0.030 |
Why?
|
| Gene Transfer Techniques | 2 | 2010 | 1204 | 0.030 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 132 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 141 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 884 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2012 | 143 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 191 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 84 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2013 | 270 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2012 | 153 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 1972 | 0.020 |
Why?
|
| Genes, p16 | 2 | 2003 | 159 | 0.020 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 8 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 9185 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2014 | 419 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1991 | 130 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 1991 | 176 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 778 | 0.020 |
Why?
|
| Cyclin T | 1 | 2010 | 19 | 0.020 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2010 | 16 | 0.020 |
Why?
|
| Materia Medica | 1 | 2010 | 14 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 783 | 0.020 |
Why?
|
| Anilides | 1 | 2014 | 409 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2011 | 415 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 459 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2000 | 1155 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 891 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 10755 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2018 | 1737 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2010 | 110 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2380 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 453 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1989 | 2208 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2014 | 484 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2011 | 277 | 0.020 |
Why?
|
| Sheep | 1 | 1993 | 1441 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2010 | 203 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 1529 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39262 | 0.020 |
Why?
|
| Cisplatin | 1 | 2016 | 1643 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 20 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1992 | 576 | 0.020 |
Why?
|
| Plasminogen Inactivators | 1 | 1989 | 37 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2018 | 54306 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6538 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2698 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2009 | 2058 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2009 | 108 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2003 | 1249 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 1954 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2021 | 42056 | 0.020 |
Why?
|
| Cricetinae | 1 | 1993 | 2427 | 0.020 |
Why?
|
| Mouth Mucosa | 2 | 2005 | 426 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 426 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1992 | 685 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 101 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 296 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 317 | 0.020 |
Why?
|
| Castration | 1 | 2008 | 153 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2014 | 858 | 0.020 |
Why?
|
| Iron | 1 | 2017 | 1786 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2009 | 311 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 2529 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1129 | 0.020 |
Why?
|
| Calcium | 2 | 2008 | 5725 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 551 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1993 | 1167 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1199 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2012 | 836 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2010 | 330 | 0.020 |
Why?
|
| SEER Program | 1 | 2013 | 1530 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 295 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 602 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 599 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1992 | 1516 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 752 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2010 | 439 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 978 | 0.020 |
Why?
|
| Leucine | 1 | 2009 | 547 | 0.020 |
Why?
|
| Risk | 2 | 2012 | 9632 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8556 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2009 | 279 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 231 | 0.020 |
Why?
|
| Flavonoids | 1 | 2010 | 445 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1763 | 0.020 |
Why?
|
| Oxazines | 1 | 2009 | 341 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2009 | 343 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12427 | 0.020 |
Why?
|
| Holoenzymes | 1 | 2006 | 40 | 0.020 |
Why?
|
| Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2009 | 308 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2008 | 825 | 0.020 |
Why?
|
| Staurosporine | 1 | 2008 | 242 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2006 | 62 | 0.020 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2006 | 36 | 0.020 |
Why?
|
| Limonins | 1 | 2006 | 23 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1490 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 470 | 0.020 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2006 | 38 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2001 | 1351 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 3613 | 0.020 |
Why?
|
| CpG Islands | 1 | 2011 | 1221 | 0.020 |
Why?
|
| Interphase | 1 | 2006 | 228 | 0.020 |
Why?
|
| Acute Disease | 1 | 1997 | 7268 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1992 | 1557 | 0.020 |
Why?
|
| Triterpenes | 1 | 2006 | 81 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2006 | 119 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1832 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 2693 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2006 | 172 | 0.020 |
Why?
|
| Minute virus of mice | 1 | 1985 | 5 | 0.020 |
Why?
|
| Parvovirus | 1 | 1985 | 4 | 0.020 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2005 | 46 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2006 | 198 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 115 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 772 | 0.020 |
Why?
|
| Cyclin A | 1 | 2005 | 60 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2326 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1737 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2006 | 195 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2005 | 58 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2008 | 1155 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2011 | 1131 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 1006 | 0.020 |
Why?
|
| Tyrosine | 1 | 2009 | 1438 | 0.020 |
Why?
|
| Keratins | 1 | 2006 | 497 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2008 | 638 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12159 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1157 | 0.020 |
Why?
|
| Extremities | 1 | 2010 | 867 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 315 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 736 | 0.010 |
Why?
|
| China | 1 | 2010 | 2339 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2004 | 115 | 0.010 |
Why?
|
| Granulocytes | 1 | 2006 | 551 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1985 | 212 | 0.010 |
Why?
|
| Endothelium | 1 | 1987 | 764 | 0.010 |
Why?
|
| Survival Rate | 2 | 2010 | 12810 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11152 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2101 | 0.010 |
Why?
|
| Rabbits | 1 | 2010 | 4773 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 2004 | 81 | 0.010 |
Why?
|
| Cystadenoma | 1 | 2004 | 79 | 0.010 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2004 | 97 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3157 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1993 | 2063 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 413 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 1115 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1500 | 0.010 |
Why?
|
| Threonine | 1 | 2004 | 272 | 0.010 |
Why?
|
| Necrosis | 1 | 2007 | 1612 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 151 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 189 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 2006 | 562 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2018 | 4642 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2006 | 496 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2003 | 234 | 0.010 |
Why?
|
| Biopsy | 1 | 2014 | 6771 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2003 | 553 | 0.010 |
Why?
|
| Piperidines | 1 | 2010 | 1650 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2003 | 298 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2418 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8623 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2753 | 0.010 |
Why?
|
| RNA Stability | 1 | 2004 | 333 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4286 | 0.010 |
Why?
|
| Autophagy | 1 | 2009 | 1337 | 0.010 |
Why?
|
| Hindlimb | 1 | 2003 | 510 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 2001 | 53 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 928 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2003 | 584 | 0.010 |
Why?
|
| Internet | 1 | 2012 | 3078 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2001 | 188 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1959 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 900 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1744 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 835 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2002 | 495 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 687 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12531 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15286 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 1999 | 225 | 0.010 |
Why?
|
| Mouth | 1 | 2001 | 380 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2002 | 660 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 1720 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 1495 | 0.010 |
Why?
|
| Leukoedema, Oral | 1 | 1977 | 1 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2001 | 824 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 2798 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 1989 | 278 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1674 | 0.010 |
Why?
|
| Proteome | 1 | 2007 | 1855 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2001 | 557 | 0.010 |
Why?
|
| Leukoplakia, Oral | 1 | 1977 | 77 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 1970 | 3149 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3802 | 0.010 |
Why?
|
| Lichen Planus | 1 | 1977 | 71 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4925 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1989 | 2186 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20509 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1977 | 183 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1995 | 72 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 1995 | 68 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1970 | 6379 | 0.010 |
Why?
|
| Vaccines | 1 | 2004 | 832 | 0.010 |
Why?
|
| Insulin | 1 | 1970 | 6596 | 0.010 |
Why?
|
| Epitopes | 1 | 2001 | 2503 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2636 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1970 | 3454 | 0.010 |
Why?
|
| Mouth Diseases | 1 | 1977 | 238 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1913 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1995 | 346 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1827 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8552 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 2138 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22052 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2003 | 2725 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1854 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5745 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 4193 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 4350 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1991 | 377 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1991 | 630 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 3390 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5132 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7344 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 36053 | 0.000 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1991 | 1126 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 36286 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80345 | 0.000 |
Why?
|
| Sulfur Radioisotopes | 1 | 1987 | 113 | 0.000 |
Why?
|
| Ligands | 1 | 1991 | 3276 | 0.000 |
Why?
|
| Methionine | 1 | 1987 | 569 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1989 | 1074 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74333 | 0.000 |
Why?
|
| Fibronectins | 1 | 1987 | 722 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1970 | 888 | 0.000 |
Why?
|
| Epithelium | 1 | 1987 | 1605 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1977 | 12968 | 0.000 |
Why?
|
| Smoking | 1 | 1977 | 9073 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1970 | 5890 | 0.000 |
Why?
|
| Obesity | 1 | 1970 | 12919 | 0.000 |
Why?
|